
U.S. Biomedical Refrigerators and Freezers Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The U.S. biomedical refrigerators and freezers market was valued at USD 1.4 billion in 2024 and is projected to grow from USD 1.5 billion in 2025 to USD 2.4 billion by 2034, expanding at a CAGR of 5.1%, according to the latest report published by Global Market Insights Inc. This steady growth is stimulated by various factors, including rising government support for research activities and clinical trials in the U.S., a growing geriatric population, technological advancements in biomedical refrigerators and freezers, and increasing advancement in biopharmaceuticals.

The U.S. biomedical refrigerators and freezers market grew from USD 1.30 billion in 2021 to USD 1.39 billion in 2023. This growth is primarily driven by the increasing demand for temperature-sensitive biologics, vaccines, and blood components, along with the expansion of research labs, biobanks, and healthcare infrastructure. Stringent regulatory standards and the growing adoption of advanced cold storage technologies further support this growth. Major companies in the market, including Thermo Fisher Scientific, Helmer Scientific, PHC Corporation, Eppendorf, and Follett Products, are focusing on innovation, energy efficiency, and smart monitoring solutions to meet evolving market needs.
Rising government support for research activities and clinical trials is a key factor driving the growth of the U.S. biomedical refrigerators and freezers market. Federal agencies, such as the National Institutes of Health (NIH), continue to invest billions annually in biomedical research and development, including clinical trials that require precise and reliable cold storage solutions for biological samples, vaccines, and investigational drugs. This sustained funding not only accelerates innovation in life sciences but also increases the demand for advanced refrigeration technologies that ensure the integrity of temperature-sensitive materials.
Further, the growing aging population in the U.S. is another major driver of the U.S. biomedical refrigerators and freezers market. Older adults are more prone to chronic illnesses such as diabetes, cancer, and cardiovascular diseases, which often require treatments involving temperature-sensitive medications, vaccines, and biological samples. As demand for geriatric care rises, healthcare providers are investing in advanced cold storage solutions to maintain the safety and effectiveness of these treatments. For example, in 2022, the U.S. had approximately 57.8 million adults aged 65 and older, highlighting a demographic shift that is fueling the need for long-term care facilities and outpatient clinics, all of which rely on biomedical refrigeration to store critical medical supplies. This trend is significantly contributing to the expansion of the biomedical refrigerators and freezers market.
Biomedical refrigerators and freezers are essential equipment used across the pharmaceutical research and healthcare sectors. They are designed to store vaccines, medications, biological samples, and other temperature-sensitive materials, ensuring they remain stable and effective by maintaining precise and controlled environmental conditions. These devices help preserve the integrity and potency of critical substances used in medical treatments and scientific research.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2024 |
| Market Size in 2024 | USD 1.4 Billion |
| Market Size in 2025 | USD 1.5 Billion |
| Forecast Period 2025 to 2034 CAGR | 5.1% |
| Market Size in 2034 | USD 2.2 Billion |
| Key Market Trends | |
| Drivers | Impact |
| Rising government support for research activities and clinical trials in the U.S. | The increasing demand for high-performance cold storage systems ensures the safe storage of biologics, medications, and diagnostic samples, thereby accelerating market growth. |
| Increasing geriatric population base | Drives the need for chronic disease management and temperature-sensitive treatments, leading to higher adoption of biomedical refrigeration in healthcare settings. |
| Technological advancements in biomedical refrigerators and freezers | Improved energy efficiency, safety, and reliability make these systems more attractive to hospitals, labs, and research centers, thus expanding the market. |
| Rising advancements in biopharmaceuticals | Necessitates strict storage compliance, boosting demand for certified and specialized refrigeration units tailored to sensitive biological products. |
| Pitfalls & Challenges | Impact |
| High cost of biomedical refrigerators and freezers | Limits adoption among small clinics and low-resource healthcare settings, slowing market growth. |
| Release of hydrofluorocarbons from refrigerators and freezers have deleterious impact on environment | Raise environmental concerns, prompting stricter regulations and demand for eco-friendly alternatives. |
| Opportunities: | Impact |
| Integration with smart technologies | Real-time monitoring, automation, and data logging create new value propositions, enhancing product appeal and driving innovation in the market. |
| Market Leaders (2024) | |
| Market Leaders |
25.2% market share |
| Top Players |
Collective market share in 2024 is 40.5% |
| Competitive Edge |
|

The U.S. market was valued at USD 1.30 billion in 2021. The market size reached USD 1.39 billion in 2023, from USD 1.34 billion in 2022.
Based on the product, the market is segmented into plasma freezers, blood bank refrigerators, lab refrigerators, lab freezers, ultra-low temperature freezers, and shock freezers. The lab refrigerators segment dominated the market in 2024, holding the largest share due to the widespread adoption across research laboratories, diagnostic centers, and hospitals for storing reagents, samples, and other temperature sensitive materials.
This segment was valued at USD 388.5 million in 2024 and is projected to reach USD 651.6 million by 2034, growing at a CAGR of 5.4%. In comparison, the blood bank refrigerators segment, valued at USD 217.8 million in 2024, is expected to grow to USD 372.2 million by 2034, with a CAGR of 5.6%.

Based on end use, the U.S biomedical refrigerators and freezers market is segmented into blood banks, pharmacies, hospitals, research labs, diagnostic centers, and other end users. The diagnostic centers segment accounted for the highest market share of 36.8% in 2024.
Few of the prominent players operating in the U.S. biomedical refrigerators and freezers industry include:
Eppendorf is known for its CryoCube ULT freezers, which feature advanced insulation, energy-efficient cooling systems, and digital monitoring through VisioNize. These units provide reliable long-term storage for high-value biological samples, making them ideal for clinical, pharmaceutical, and research applications.
Thermo Fisher Scientific’s biomedical refrigerators and freezers are distinguished by advanced cooling technologies and energy-efficient designs, such as the TSX Series with V-drive technology. These systems ensure precise temperature control, regulatory compliance, and sustainable performance, making them ideal for critical sample storage in healthcare and research settings.
B Medical Systems specializes in medical refrigeration and vaccine cold chain solutions, offering high-performance refrigerators, freezers, and transport boxes for hospitals, labs, and humanitarian missions. Products such as the Laboratory Refrigerator L290 provide precise cooling and reliable storage for vaccines, blood, and biological samples, supported by eco-friendly systems and remote monitoring.
Market, By Product
Market, By End Use
The segment featuring IoT-enabled monitoring, real-time temperature tracking, and cloud integration is projected to grow from USD 388.5 million in 2024 to USD 651.6 million by 2034, at a CAGR of 5.4%.
Key players include Aegis Scientific, Azbil Corporation, Arctiko, B Medical Systems, Cardinal Health, Eppendorf, Follett Products, Helmer Scientific, Haier Biomedical, Migali Scientific, NuAire, and PHC Corporation.
Key trends include IoT-enabled monitoring, real-time temperature tracking, cloud integration, energy-efficient designs, and environmentally friendly solutions to reduce operational costs and meet sustainability goals.
The diagnostic centers segment accounted for the highest market share of 36.8% in 2024.
The blood bank refrigerators segment was valued at USD 217.8 million in 2024 and is expected to grow at a CAGR of 5.6% through 2034.
The market size was valued at USD 1.4 billion in 2024, with a CAGR of 5.1% expected through 2034, driven by government support for research activities, a growing geriatric population, and advancements in technology and biopharmaceuticals.
The market is projected to grow to USD 1.5 billion in 2025.
The market is expected to reach USD 2.4 billion by 2034, fueled by technological innovations, energy-efficient solutions, and increasing demand from healthcare and research sectors.


